• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in

Blog

Featured post

Regulatory-grade device evidence reimagined with new precision data

By linking unique device identifier (UDI) data with minute-level Admission–Discharge–Transfer (ADT), procedure logs, and chargemaster data, Truveta delivers the full picture of when, how, and in what context devices are used—accelerating regulatory submissions, health economics and outcomes research (HEOR), safety monitoring, and more.

Read more
RWD RWE medical device research safety effectiveness HEOR EHR chargemaster unique device identifier ADT ICU procedure logs
Research
Data
Technology
News & events
Truveta CEO shares perspective on healthcare system. Truveta's mission is saving lives with data.
News

Healthcare is complicated…

  • Terry Myerson, CEO
  • August 1, 2023
Unraveling Rare Diseases: Truveta's Impactful Research on Patient Populations - Explore real-time data insights for rare diseases research.
Data

A journey into rare disease research

  • Truveta staff
  • July 31, 2023
Research

New research uses Truveta Data to study treatment for hospitalized pregnant patients with COVID-19

  • Truveta staff
  • July 28, 2023
ResearchResearch Insights

Real-time monitoring of prescription trends and demographics of two SGLT2i drugs

  • Truveta Research
  • July 10, 2023
Technology

Unlocking real-world data for cardiovascular research: The promise of complete and clean EHR data for drug and device development

  • Truveta staff
  • June 20, 2023
truveta
News

Building a learning public health system

  • Terry Myerson, CEO
  • June 20, 2023
Research

Alzheimer’s disease research: A new era

  • Truveta staff
  • June 15, 2023
ResearchResearch Insights

Ozempic, Wegovy, and Mounjaro: On- and off-label prescribing trends

  • Truveta Research
  • June 6, 2023
Truveta Language Model
News

A pragmatic suggestion for medical AI regulation

  • Terry Myerson, CEO
  • May 30, 2023
« Previous 1 … 22 23 24 25 26 … 41 Next »

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.